Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity

Digestive Diseases and Sciences

Volumn 43, Issue 12, 1998, Pages 2727-2732

  Sandha, Gurpal S ^a   Leblanc, Robin ^a   Veldhuyzen Van Zanten, Sander J O ^a   Sitland, Troy D ^a   Agocs, Lisa ^a   Burford, Neil ^a   Best, Linda ^a   Mahoney, David ^a   Hoffman, Paul ^a   Leddin, Desmond J ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Chemical structure; Colloidal bismuth subcitrate; Experimental gastric ulcer; Helicobacter pylori

Indexed keywords

1,2 [BIS(1,3 DITHIA 2 BISMOLANE)THIO]ETHANE; 2 CHLORO 1,3 DITHIA 2 BISMOLANE; BISMUTH; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFICACY; DRUG SENSITIVITY; DRUG STRUCTURE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION; STOMACH ULCER;

ANIMALS; ANTACIDS; BISMUTH; HELICOBACTER PYLORI; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; RATS; RATS, WISTAR; STOMACH ULCER;

EID: 0032443399     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026667714603     Document Type: Article

References (30)

1. Marshall BJ: The use of bismuth in gastroenterology. Am J Gastroenterol 86:16-25, 1991
2. Gorbach SL: Bismuth therapy in gastrointestinal diseases. Gastroenterology 99:863-875, 1990
3. Manhart MD: In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts. Rev Infect Dis 12(suppl 1):S11-S15, 1990
4. DuPont HL, Sullivan P, Pickering LK, Haynes C, Ackerman PB: Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican University. Gastroenterology 73:715-718, 1977
5. DuPont HL, Sullivan P, Evans DG, Pickering LK, Evans DJ, Vollet JJ, Ericsson CD, Ackerman PB, Tjoa WS: Prevention of traveler's diarrhea (emporiatric enteritis): Prophylactic administration of subsalicylate bismuth. JAMA 243:237-241, 1980
6. Srivastava ED, Swift GL, Wilkinson S, Williams GT, Evans BK, Rhodes J: Tripotassium dicitrato bismuthate enemas in the treatment of ulcerative proctitis. Aliment Pharmacol Ther 4:577-581, 1990
7. Tsai HH, Dwarkanath AD, Hart CA, Milton JD, Rhodes JM: Increased faecal mucin sulphatase activity in ulcerative colitis: A potential target for treatment. Gut 36:570-576, 1995
8. Ryder SD, Walker RJ. Jones H, Rhodes JM: Rectal bismuth subsalicylate as therapy for ulcerative colitis. Aliment Pharmacol Ther 4:333-338, 1990
9. Tytgat GNJ: Colloidal bismuth sub-citrate in peptic ulcer - a review. Digestion 37(suppl 2):31-41, 1987
10. Sutton DR: Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapses. Gut 23:621-624, 1982
11. Veldhuyzen van Zanten SJO, Sherman PM: Indications for treatment of Helicobacter pylori infection: A systematic overview. Can Med Assoc J 150(2):189-198, 1994
12. Hermann WA, Herdtweck E, Pajdla L: Colloidal bismuth sub-citrate (CBS): Isolation and structural characterization of the active substance against Helicobacter pylori, a causal factor of gastric diseases. Inorg Chem 30(12):2579-2581, 1991
13. Asato E, Katsura K, Mikuriya M, Turpeinen U, Mutikainen I, Reedijk J: Synthesis, structure and spectroscopic properties of bismuth citrate compounds and bismuth-containing ulcer healing agent colloidal bismuth sub-citrate (CBS). Inorg Chem 34:2447-2454, 1995
14. 2O. J Chem Soc Dalton Trans 1996:2417-2422, 1996
15. Agocs L, Burford N, Cameron TS, Curtis JM, Richardson JF, Robertson KN, Yhard GB: Spectroscopic, structural and mass spectroscopic studies on two systematic series of dithiabismuth heterocycles: Identification of bismuthenium cations and their solvent complexes. J Am Chem Soc 118:3225-3232, 1996
16. Inauen W, Wyss PA, Kayser S, Baumgartner A, Schurer-Maly CC, Koelz HR, Halter F: Influence of prostaglandins, omeprazole and indomethacin on healing of experimental gastric ulcers in the rat. Gastroenterology 95:636-641, 1988
17. Konturek SJ, Radecki T, Piastucki I, Drozdowicz D: Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate. Digestion 37(suppl 2):8-15, 1987
18. Hall DWR, van den Hoven WE: Protective properties of colloidal bismuth subcitrate on gastric mucosa. Scand J Gastroenterol 26(suppl 122):11-13, 1986
19. Elliot SN, McKnight W, Cirino G, Wallace JL: A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 109:524-530, 1995
20. Beil W, Bierbaum S, Sewing K-F: Studies on the mechanism of action of colloidal bismuth subcitrate. Pharmacology 47:141-144, 1993
21. Marshall BJ, Armstrong JA, Francis GJ, Nokes NT, Wee SH: Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion 37(suppl 2):16-30, 1987
22. Armstrong JA, Wee SH, Goodwin CS, Wilson DH: Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro - an ultrastructural study. J Med Microbiol 24:343-350, 1987
23. Wieriks J, Hespe W, Jaitly KD, Koekkock PH, Lavy U: Pharmacological properties of colloidal bismuth subcitrate (CBS, Denol). Scand J Gastroenterol 17(suppl 80):11-16, 1982
24. Baron JH, Barr J, Batten J, Sidebotham R, Spencer J: Acid, pepsin and mucus secretion in patients with gastric and duodenal ulcers before and after colloidal bismuth subcitrate (Denol). Gut 27:486-490, 1986
25. Waldum HL, Qvigstad G, Marvik R, Brenna E, Syverson U, Sandvik AK: The effect of tripotassium dicitrato bismuthate on the rat stomach. Aliment Pharmacol Ther 8:425-431, 1994
26. Konturek SJ, Radecki T, Piastucki I, Brzozowski T, Drozdowicz D: Gastrocytoprotection by colloidal bismuth subcitrate (Denol) and sucralfate. Role of endogenous prostaglandins. Gut 28:201-205, 1987
27. Malandrino S, Bestetti A, Fumagalli G, Borsa M, Vigano T, Tonon G: Role of endogenous prostaglandins in protection of rat gastric mucosa by tripotassium dicitrate bismuthate. Scand J Gastroenterol 22:943-948, 1987
28. Lee SP: A potential mechanism of action of colloidal bismuth subcitrate: Diffusion barrier to hydrochloric acid. Scand J Gastroenterol 17(suppl 80):17-21, 1982
29. Koo J, Ho J, Lam SK, Wong J, Ong GB: Selective coating of gastric ulcer by tripotassium dicitratobismuthate in the rat. Gastroenterology 82:864-870, 1982
30. Konturek SJ, Dembinski A, Warzecha Z, Bielanski W, Brzozowski T, Drozdowicz D: Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats. Gut 29:894-902, 1988